As Kansas City Southern (KSU) Market Valuation Rose, Shareholder Marlowe Partners LP Has Decreased Holding; Biocryst Pharmaceuticals (BCRX) Holding Held by Ra Capital Management Llc

February 22, 2018 - By reb123z

Peter Kolchinsky increased its stake in Biocryst Pharmaceuticals (BCRX) by 35.3% based on its latest 2017Q3 regulatory filing with the SEC. Ra Capital Management Llc bought 1.82M shares as the company’s stock declined 16.46% while stock markets rallied. The hedge fund run by Peter Kolchinsky held 6.98 million shares of the health care company at the end of 2017Q3, valued at $36.60 million, up from 5.16 million at the end of the previous reported quarter. Ra Capital Management Llc who had been investing in Biocryst Pharmaceuticals for a number of months, seems to be bullish on the $482.32 million market cap company. The stock decreased 3.16% or $0.16 during the last trading session, reaching $4.9. About 804,844 shares traded. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has risen 75.08% since February 22, 2017 and is uptrending. It has outperformed by 58.38% the S&P500.




Marlowe Partners Lp decreased its stake in Kansas City Southern (KSU) by 8.18% based on its latest 2017Q3 regulatory filing with the SEC. Marlowe Partners Lp sold 12,283 shares as the company’s stock rose 3.89% with the market. The institutional investor held 137,927 shares of the railroads company at the end of 2017Q3, valued at $14.99 million, down from 150,210 at the end of the previous reported quarter. Marlowe Partners Lp who had been investing in Kansas City Southern for a number of months, seems to be less bullish one the $11.13B market cap company. The stock increased 0.60% or $0.64 during the last trading session, reaching $107.99. About 731,395 shares traded. Kansas City Southern (NYSE:KSU) has declined 0.27% since February 22, 2017 and is downtrending. It has underperformed by 16.97% the S&P500.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.17, from 0.86 in 2017Q2. It is positive, as 29 investors sold KSU shares while 163 reduced holdings. 69 funds opened positions while 129 raised stakes. 84.43 million shares or 2.67% less from 86.75 million shares in 2017Q2 were reported. State Common Retirement Fund holds 236,400 shares or 0.03% of its portfolio. Jane Street Grp Inc Ltd Limited Liability Company reported 0% of its portfolio in Kansas City Southern (NYSE:KSU). Hudock Cap Grp Llc owns 22 shares or 0% of their US portfolio. Wealthtrust reported 0.02% stake. Advisor Prtn Limited Liability Co holds 0.04% or 1,992 shares in its portfolio. Apg Asset Mgmt Nv reported 49,980 shares. Moreover, First Republic Management has 0.01% invested in Kansas City Southern (NYSE:KSU). State Board Of Administration Of Florida Retirement Systems holds 167,435 shares or 0.05% of its portfolio. Colorado-based Public Employees Retirement Association Of Colorado has invested 0.02% in Kansas City Southern (NYSE:KSU). Amer Bankshares reported 0.01% stake. Commerce Retail Bank accumulated 0.03% or 21,693 shares. Schroder Invest Gru accumulated 42,756 shares. Suffolk Capital Management Ltd Co holds 129,062 shares or 1.85% of its portfolio. Victory Capital Inc accumulated 36,461 shares or 0.01% of the stock. Aqr Cap Mgmt Ltd Co has 0% invested in Kansas City Southern (NYSE:KSU).

Analysts await Kansas City Southern (NYSE:KSU) to report earnings on April, 20. They expect $1.42 earnings per share, up 21.37% or $0.25 from last year’s $1.17 per share. KSU’s profit will be $146.34M for 19.01 P/E if the $1.42 EPS becomes a reality. After $1.38 actual earnings per share reported by Kansas City Southern for the previous quarter, Wall Street now forecasts 2.90% EPS growth.

Since August 28, 2017, it had 1 buying transaction, and 2 selling transactions for $775,947 activity. Zozaya Delano Jose Guillermo also sold $617,567 worth of Kansas City Southern (NYSE:KSU) on Monday, August 28. The insider Maier Henry J bought $104,345.

Among 24 analysts covering Kansas City Southern (NYSE:KSU), 13 have Buy rating, 1 Sell and 10 Hold. Therefore 54% are positive. Kansas City Southern had 79 analyst reports since August 20, 2015 according to SRatingsIntel. The stock of Kansas City Southern (NYSE:KSU) earned “Buy” rating by Stifel Nicolaus on Friday, October 20. Citigroup maintained Kansas City Southern (NYSE:KSU) on Tuesday, April 19 with “Buy” rating. Credit Suisse maintained the shares of KSU in report on Friday, February 19 with “Neutral” rating. Citigroup maintained it with “Buy” rating and $123 target in Wednesday, October 4 report. Oppenheimer initiated the shares of KSU in report on Thursday, June 16 with “Outperform” rating. The stock has “Neutral” rating by Atlantic Securities on Thursday, August 11. Cowen & Co maintained Kansas City Southern (NYSE:KSU) on Monday, April 24 with “Market Perform” rating. The company was maintained on Friday, September 11 by Bank of America. The firm earned “Underperform” rating on Thursday, May 19 by CLSA. RBC Capital Markets maintained Kansas City Southern (NYSE:KSU) rating on Monday, October 19. RBC Capital Markets has “Outperform” rating and $106 target.

Since September 18, 2017, it had 0 insider purchases, and 1 insider sale for $294,035 activity.

Investors sentiment increased to 1.69 in 2017 Q3. Its up 0.01, from 1.68 in 2017Q2. It improved, as 12 investors sold BCRX shares while 24 reduced holdings. 28 funds opened positions while 33 raised stakes. 79.80 million shares or 20.47% more from 66.24 million shares in 2017Q2 were reported. Bancorporation Of Ny Mellon Corporation invested 0% of its portfolio in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Parametric Port Assocs Limited Liability holds 0% in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) or 11,072 shares. Rock Springs Management LP holds 450,000 shares or 0.11% of its portfolio. Citigroup Inc reported 28,255 shares. Michigan-based Comerica Comml Bank has invested 0% in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Tekla Capital Ltd Liability holds 323,255 shares or 0.06% of its portfolio. Deerfield Management holds 4.98 million shares or 1.17% of its portfolio. Laurion Capital LP has invested 0.01% of its portfolio in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). 6.01 million were accumulated by Vanguard. State Common Retirement Fund holds 83,800 shares. Swiss Commercial Bank stated it has 0% in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Proshare Advsr Ltd Co reported 50,807 shares. Ameritas Inv Prtnrs holds 6,697 shares or 0% of its portfolio. Alliancebernstein Lp stated it has 0% of its portfolio in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Morgan Stanley reported 362,140 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts